Home Boronic Acids 1107627-21-3
1107627-21-3,MFCD16036273
Catalog No.:AA0083A4

1107627-21-3 | (1-Methyl-1H-benzimidazol-5-yl)boronic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98+%
in stock  
$91.00   $64.00
- +
1g
98+%
in stock  
$241.00   $169.00
- +
5g
98+%
in stock  
$931.00   $652.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0083A4
Chemical Name:
(1-Methyl-1H-benzimidazol-5-yl)boronic acid
CAS Number:
1107627-21-3
Molecular Formula:
C8H9BN2O2
Molecular Weight:
175.9803
MDL Number:
MFCD16036273
SMILES:
OB(c1ccc2c(c1)ncn2C)O
Properties
Computed Properties
 
Complexity:
191  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  

Downstream Synthesis Route
1107627-21-3   
6-chloro-N-(2-methoxypyridin-4-yl)-2-morpholinopyrimidin-4-amine 
 
N-(2-methoxypyridin-4-yl)-6-(1-methyl-1H-benzodimidazol-5-yl)-2-morpholinopyrimidin-4-amine 

[1]CurrentPatentAssignee:BIOMARINPHARMACEUTICALINC-WO2016/57834,2016,A1Locationinpatent:Paragraph000171;000190

2-chloro-7-fluoro-4H-pyrido1,2-apyrimidin-4-one 
  1107627-21-3   
7-fluoro-2-(1-methylbenzimidazol-5-yl)pyrido1,2-apyrimidin-4-one 

[1]Ratni,Hasane;Karp,GaryM.;Weetall,Marla;Naryshkin,NikolaiA.;Paushkin,SergeyV.;Chen,KarenS.;McCarthy,KathleenD.;Qi,Hongyan;Turpoff,Anthony;Woll,MatthewG.;Zhang,Xiaoyan;Zhang,Nanjing;Yang,Tianle;Dakka,Amal;Vazirani,Priya;Zhao,Xin;Pinard,Emmanuel;Green,Luke;David-Pierson,Pascale;Tuerck,Dietrich;Poirier,Agnes;Muster,Wolfgang;Kirchner,Stephan;Mueller,Lutz;Gerlach,Irene;Metzger,Friedrich[JournalofMedicinalChemistry,2016,vol.59,#13,p.6086-6100]

1107627-21-3   
4-bromo-Ν-α-(trans-4-(tert-butoxycarbonyl)aminomethyl}cyclohexyl)carbonyl-N-4-(2H-tetrazol-5-yl)phenyl-L-phenylalaninamide 
 
Ν-α-(trans-4-(tert-butoxycarbonyl)aminomethyl}cyclohexyl)carbonyl-4-(1-methyl-1H-benzimidazol-5-yl)-N-4-(2H-tetrazol-5-yl)phenyl-L-phenylalaninamide 

[1]CurrentPatentAssignee:BAYERAG-TW2016/5809,2016,ALocationinpatent:Page/Pagecolumn60;61

1107627-21-3   
(2E)-3-(4-chloropyridin-3-yl)-N-(4-(N-morpholinylmethyl)phenyl)acrylamide 
 
(2E)-3-4-(1-methyl-1H-1,3-benzodiazol-5-yl)pyridin-3-yl-N-{4-(morpholin-4-yl)methylphenyl}acrylamide 

[1]Fujimoto,Jun;Hirayama,Takaharu;Hirata,Yasuhiro;Hikichi,Yukiko;Murai,Saomi;Hasegawa,Maki;Hasegawa,Yuka;Yonemori,Kazuko;Hata,Akito;Aoyama,Kazunobu;Cary,DouglasR.[BioorganicandMedicinalChemistry,2017,vol.25,#12,p.3018-3033]

1107627-21-3   
C22H24ClN5O4S 
 
C23H24ClN5O2 

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2018/65365,2018,A1Locationinpatent:Page/Pagecolumn146

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1107627-21-3 Molecular Formula|1107627-21-3 MDL|1107627-21-3 SMILES|1107627-21-3 (1-Methyl-1H-benzimidazol-5-yl)boronic acid